24871 | 24871 | A Phase 1 Study of the Safety and Immunogenicity of Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine in Healthy Adults | Active, not recruiting | No Results Available | Safety|Tolerability|Reactogenicity | Biological: PA83-FhCMB | https://ClinicalTrials.gov/show/NCT02239172 |
24872 | 24872 | Acupuncture-assisted-anesthesia to Improve Postoperative Outcome After Digestive Surgery in Elderly Patients | Recruiting | No Results Available | Postoperative Complications|Surgery | Other: TES(transcutaneous electric stimulation) | https://ClinicalTrials.gov/show/NCT02239159 |
24873 | 24873 | Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass | Completed | No Results Available | Acquired Bleeding Disorder|Cardiac Surgery Requiring Cardiopulmonary Bypass | Drug: catridecacog|Drug: placebo | https://ClinicalTrials.gov/show/NCT02239146 |
24874 | 24874 | R&D Supporting Pilot Study for the Assessment of the Safety and Effectiveness of the ProVATE (ProTIPI) Vaginal Pessary | Active, not recruiting | No Results Available | Pelvic Organ Prolapse | Device: ProVATE vaginal pessary | https://ClinicalTrials.gov/show/NCT02239133 |
24875 | 24875 | Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) | Recruiting | No Results Available | Stroke|Secondary Prevention | Drug: optional ASA as comedication|Drug: placebo to ASA|Drug: placebo to optional ASA as comedication|Drug: placebo to dabigatran etexilate|Drug: ASA 100 mg|Drug: dabigatran etexilate | https://ClinicalTrials.gov/show/NCT02239120 |
24876 | 24876 | N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome | Completed | No Results Available | Polycystic Ovary Syndrome | Drug: N-Acetyl cysteine|Procedure: laparoscopic ovarian drilling | https://ClinicalTrials.gov/show/NCT02239107 |
24877 | 24877 | Biosignatures of Latuda for Bipolar Depression | Recruiting | No Results Available | Bipolar Depression | Drug: Lurasidone (Latuda) | https://ClinicalTrials.gov/show/NCT02239094 |
24878 | 24878 | A Safety and Tolerability Study of CTP-730 in Healthy Volunteers | Completed | No Results Available | Healthy | Drug: CTP-730|Drug: Placebo for CTP-730 | https://ClinicalTrials.gov/show/NCT02239081 |
24879 | 24879 | CT Residual Gastric Fluid Volume | Enrolling by invitation | No Results Available | Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation | | https://ClinicalTrials.gov/show/NCT02239068 |
24880 | 24880 | Staff Nurse Perceptions of MBT Skills Training for Working With BPD in AMH | Completed | No Results Available | Borderline Personality Disorder. | | https://ClinicalTrials.gov/show/NCT02239055 |
24881 | 24881 | Effect of Low-level Laser Therapy on Palatal Wound Healing | Completed | No Results Available | Palatal Wound | Procedure: LLLT | https://ClinicalTrials.gov/show/NCT02239042 |
24882 | 24882 | Platelet Rich Plasma on Osteoarthritis of Knee | Recruiting | No Results Available | Knee Osteoarthritis | Drug: platelet rich plasma|Drug: Normal saline | https://ClinicalTrials.gov/show/NCT02239029 |
24883 | 24883 | Screening Patients With Sickle Cell Disease for Kidney Damage | Recruiting | No Results Available | Sickle Cell Disease | | https://ClinicalTrials.gov/show/NCT02239016 |
24884 | 24884 | NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment | Recruiting | No Results Available | Mild Cognitive Impairment | Drug: DAOIB|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02239003 |
24885 | 24885 | Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions | Recruiting | No Results Available | The Study Focusses on the Evaluation of New Tissue Biomarkers for Cervical Cancer and Its Preinvasive Lesions. | | https://ClinicalTrials.gov/show/NCT02238990 |
24886 | 24886 | Bupropion for Depression in ESRD Patients on Hemodialysis | Recruiting | No Results Available | Major Depression|End Stage Renal Disease | Drug: Fluoxetine|Drug: Bupropion | https://ClinicalTrials.gov/show/NCT02238977 |
24887 | 24887 | Reinforcement of Closure of Stoma Site | Recruiting | No Results Available | Hernia | Device: Stratticeâ„¢ Reconstructive Tissue Matrix|Procedure: Standard Closure | https://ClinicalTrials.gov/show/NCT02238964 |
24888 | 24888 | Cancer Care Coordination for Chemotherapy Patients | Not yet recruiting | No Results Available | Cancer | Other: Mobile Health (mHealth)|Other: No mHealth | https://ClinicalTrials.gov/show/NCT02238951 |
24889 | 24889 | Piecemeal Versus En Bloc Resection of Large Rectal Adenomas | Recruiting | No Results Available | Colorectal Adenoma With Mild Dysplasia|Colorectal Adenoma With Severe Dysplasia|Colorectal Adenomatous Polyp|Colorectal Low Grade Intraepithelial Neoplasia|Colorectal High Grade Intraepithelial Neoplasia | Procedure: en-bloc resection|Procedure: piecemeal resection | https://ClinicalTrials.gov/show/NCT02238938 |
24890 | 24890 | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients | Active, not recruiting | No Results Available | Acute Myeloid Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)|Myelodysplastic Syndrome (MDS) | Drug: CPX-351 | https://ClinicalTrials.gov/show/NCT02238925 |
24891 | 24891 | Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai | Completed | No Results Available | Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied | Drug: kandhaga rasayanam | https://ClinicalTrials.gov/show/NCT02238912 |
24892 | 24892 | Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma | Completed | No Results Available | Medulloblastoma, Childhood|Cerebral Primitive Neuroectodermal Tumor|Ependymoma | | https://ClinicalTrials.gov/show/NCT02238899 |
24893 | 24893 | Radical Cystectomy, Nutrition and Convalescence | Completed | No Results Available | Urinary Bladder Neoplasms|Cystectomy|Bladder Cancer | Dietary Supplement: Parenteral nutrition. SMOFKABIVEN infusion in central vene. Fresenius Kabi | https://ClinicalTrials.gov/show/NCT02238886 |
24894 | 24894 | Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma | Not yet recruiting | No Results Available | Lymphoma|Neutropenia | Drug: Pegfilgrastim | https://ClinicalTrials.gov/show/NCT02238873 |
24895 | 24895 | A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis | Recruiting | No Results Available | Cirrhosis Due to Hepatitis B | Drug: Entacavir|Drug: Tenofovir | https://ClinicalTrials.gov/show/NCT02238860 |
24896 | 24896 | Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy | Recruiting | No Results Available | Pancreatic Cancer | Device: WallFlexâ„¢ Biliary RX Fully Covered/Uncovered Stent System | https://ClinicalTrials.gov/show/NCT02238847 |
24897 | 24897 | Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers | Active, not recruiting | No Results Available | Healthy | Drug: FP-025|Drug: Placebo|Drug: FP-025|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02238834 |
24898 | 24898 | Role of the MET Oncogene in Human Colorectal Cancer - A Translational Study | Recruiting | No Results Available | Colorectal Cancer | | https://ClinicalTrials.gov/show/NCT02238821 |
24899 | 24899 | A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers | Recruiting | No Results Available | Estrogen Receptor Positive Breast Cancer | Drug: Estradiol | https://ClinicalTrials.gov/show/NCT02238808 |
24900 | 24900 | Sepsis-Associated Purpura Fulminans International Registry - Europe | Not yet recruiting | No Results Available | Sepsis | | https://ClinicalTrials.gov/show/NCT02238795 |